According to the research report titled ‘Venous Thromboembolism Treatment Market Size By Device (Compression System, Thrombectomy Systems, IVC Filters, Stockings), By Application (Deep Vein Thrombosis, Pulmonary Embolism), By End-use (Hospitals, Catheterization Laboratories), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 – 2027’, available with MarketStudyReport, global venous thromboembolism treatment market is expected to record commendable growth by the year 2027.
 

Increased pervasiveness of obesity and cancer, growing elderly population, availability of advanced cath labs, and growing demand for improved healthcare solutions are the key factors driving the growth of global venous thromboembolism treatment market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3793266/

As per device type, the report cites that stockings segment is predicted to expand at 7.8% CAGR through 2027, owing to widespread product adoption to reduce pain and swelling as well as to improve blood flow.

Based on application spectrum, the deep vein thrombosis segment generated USD 530 million in 2020 and is likely to expand consistently throughout the estimated timeframe. Growing elderly population coupled with high occurrence of obesity and cancer are fueling the segmental size.

Citing the end-user landscape, global venous thromboembolism treatment industry share from catheterization laboratories is anticipated to witness a y-o-y growth rate of 9.7% through 2027, owing to growing demand for improved medical care and high patient volume in such labs.

In terms of regional scope, the U.S. generated around USD 380 million for North America venous thromboembolism treatment industry. This can be attributed to high concentration of market majors, widespread adoption of advanced products, and availability of sophisticated cath labs in the country.

Argon Medical Devices Inc., Cook Medical Inc., Daesung Maref Co. Ltd., Covidien, Cardinal Health Inc., AngioDynamics, and Boston Scientific Corporation are the major companies operating in global venous thromboembolism treatment market.